[{"Assets_0_Q1_USD":4596717000.0,"CommonStockSharesOutstanding_0_Q1_shares":176653480.0,"EarningsPerShareBasic_1_Q1_USD":-0.25,"EarningsPerShareDiluted_1_Q1_USD":-0.26,"NetIncomeLoss_1_Q1_USD":-44149000.0,"StockholdersEquity_0_Q1_USD":2807003000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":176150000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":175932000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180427"}]